Aktieanalys

Physitrack Q3 2024: A modest quarter, in line with expectations - Redeye

Redeye Publicerad: 12 Nov 09:02

Redeye shares its initial take on Physitrack’s Q3 results, which were generally in line with our modest expectations. Lifecare maintained its growth trajectory, though overall growth—reported at 1% organically—was tempered by weaker performance in the Wellness division. Highlights included stable ARR growth at 12% year over year. Given the continuation of softness in the Wellness division, we expect to make downward adjustments to our estimates and fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1055505/physitrack-q3-2024-a-modest-quarter-in-line-with-expectations?utm_source=finwire&utm_medium=RSS

Nyheter om Physitrack

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!